Congratulations to SciClone Pharmaceuticals (Holdings) Ltd. (stock code: 6600.HK) on its successful listing on the Main Board of the HKSE on 3 Mar 2021. With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services relating to equity incentive plan, financial assets, financial liabilities, total equity value and impairment test of intangible asset.
Date: 03 Mar 2021 | Tags: Business Valuation, Initial Public Offering (IPO), Financial Reporting